DK1057828T3 - Orale trovafloxacin-suspensioner - Google Patents

Orale trovafloxacin-suspensioner

Info

Publication number
DK1057828T3
DK1057828T3 DK00304550T DK00304550T DK1057828T3 DK 1057828 T3 DK1057828 T3 DK 1057828T3 DK 00304550 T DK00304550 T DK 00304550T DK 00304550 T DK00304550 T DK 00304550T DK 1057828 T3 DK1057828 T3 DK 1057828T3
Authority
DK
Denmark
Prior art keywords
suspensions
crystals
trovafloxacin
oral
novel
Prior art date
Application number
DK00304550T
Other languages
Danish (da)
English (en)
Inventor
Douglas John Meldrum Pfi Allen
Sojka Sonja Pfizer Cen Sekulic
Daniel Ray Pfizer Cent Arenson
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Application granted granted Critical
Publication of DK1057828T3 publication Critical patent/DK1057828T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
DK00304550T 1999-06-04 2000-05-30 Orale trovafloxacin-suspensioner DK1057828T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US13746399P 1999-06-04 1999-06-04

Publications (1)

Publication Number Publication Date
DK1057828T3 true DK1057828T3 (da) 2003-07-14

Family

ID=22477550

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00304550T DK1057828T3 (da) 1999-06-04 2000-05-30 Orale trovafloxacin-suspensioner

Country Status (10)

Country Link
US (1) US6239141B1 (fr)
EP (1) EP1057828B1 (fr)
JP (1) JP3465820B2 (fr)
AT (1) ATE234835T1 (fr)
BR (1) BR0002577A (fr)
CA (1) CA2311112A1 (fr)
DE (1) DE60001687T2 (fr)
DK (1) DK1057828T3 (fr)
ES (1) ES2194677T3 (fr)
PT (1) PT1057828E (fr)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20010635A1 (es) 1999-10-08 2001-08-15 Smithkline Beecham Corp Inhibidores de fab i utiles para el tratamiento de infecciones bacterianas
BR0207930A (pt) * 2001-03-05 2004-03-02 Ortho Mcneil Pharm Inc Composições farmacêuticas lìquidas com sabor mascarado
ES2320984T3 (es) * 2001-04-06 2009-06-01 Affinium Pharmaceuticals, Inc. Inhibidores de fab i.
US20030068829A1 (en) * 2001-06-25 2003-04-10 Symyx Technologies, Inc. High throughput crystallographic screening of materials
MXPA04000294A (es) * 2001-07-10 2004-05-04 Pharmacia & Upjhon Company Tiacin oxazolidinonas cristalinas.
CA2455050C (fr) 2001-08-15 2007-02-20 Pharmacia & Upjohn Company Cristaux comprenant un sel d'acide malique de n-[2-(diethylamino)ethyl]-5-[(5-fluoro-1,2-dihydro-2-oxo-3h-indol-3-ylidene)methyl]-2,4-dimethyl-1h-pyrrole-3-carboxamide, procedes de preparation associes et compositions correspondantes
PL212421B1 (pl) * 2002-03-12 2012-09-28 Bristol Myers Squibb Co Kompozycja farmaceutyczna w postaci zawiesiny kwasowego leku i sposób jej wytwarzania oraz sposób maskowania gorzkiego lub innego nieprzyjemnego smaku leku
US8367098B2 (en) * 2002-04-30 2013-02-05 The Population Council, Inc. Unique combinations of antimicrobial compositions
AU2003245252A1 (en) * 2002-04-30 2003-11-17 Fmc Corporation Carrageenan based antimicrobial compositions
ES2518316T3 (es) 2002-12-06 2014-11-05 Debiopharm International Sa Compuestos heterocíclicos, métodos de fabricación de los mismos y su uso en terapia
CA2519429C (fr) 2003-03-17 2013-08-06 Affinium Pharmaceuticals, Inc. Compositions pharmaceutiques comportant des inhibiteurs de fab i et autres antibiotiques
US20050031700A1 (en) * 2003-07-18 2005-02-10 Sanatarus, Inc. Pharmaceutical formulation and method for treating acid-caused gastrointestinal disorders
ES2515101T3 (es) 2004-06-04 2014-10-29 Debiopharm International Sa Derivados de acrilamida como agentes antibióticos
KR20080075027A (ko) * 2005-12-05 2008-08-13 아피늄 파마슈티컬스, 인크. Ｆａｂｉ 억제제 및 항박테리아제로서의헤테로시클릴아크릴아미드 화합물
EP2054422B1 (fr) 2006-07-20 2017-06-14 Debiopharm International SA Dérivés d'acrylamide en tant qu'inhibiteurs de fab i
US8263613B2 (en) * 2007-02-16 2012-09-11 Affinium Pharmaceuticals, Inc. Salts, prodrugs and polymorphs of fab I inhibitors
NZ702695A (en) 2012-06-19 2015-10-30 Debiopharm Int Sa Prodrug derivatives of (e)-n-methyl-n-((3-methylbenzofuran-2-yl)methyl)-3-(7-oxo-5,6,7,8-tetrahydro-1,8-naphthyridin-3-yl)acrylamide
US10751351B2 (en) 2016-02-26 2020-08-25 Debiopharm International S.A. Medicament for treatment of diabetic foot infections

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5164402A (en) 1989-08-16 1992-11-17 Pfizer Inc Azabicyclo quinolone and naphthyridinone carboxylic acids
US5266559A (en) 1989-10-27 1993-11-30 Firmenich S.A. Use of unsaturated macrocyclic lactones as perfuming ingredients
US5391763A (en) 1990-07-11 1995-02-21 Pfizer Inc. 3-aza-bicyclo[3.1.0]hexanes which are intermediates for anti-bacterial azabicyclo quinolone carboxylic acids
TW271400B (fr) 1992-07-30 1996-03-01 Pfizer
US5763454A (en) 1995-06-06 1998-06-09 Pfizer, Inc. Crystal form of anhydrous 7-( 1α,5α,6α!-6-amino-3-azabicyclo 3.1.0!hex-3-yl)-6-fluoro-1-(2,4-difluorophenyl)-1,4-dihydro-4-oxo-1,8 naphthyridine-3-carboxylic acid, methanessulfonic acid salt
ATE208790T1 (de) * 1995-08-29 2001-11-15 Pfizer Polymorphs von prodrug 6-n(l-ala-l-ala)- trovafloxacin
NZ312199A (en) 1995-08-29 1999-06-29 Pfizer Zwitterionic forms of trovafloxacin
US6114531A (en) * 1998-07-28 2000-09-05 Pfizer Inc. Process for preparing quinolone and naphthyridone carboxylic acids

Also Published As

Publication number Publication date
DE60001687D1 (de) 2003-04-24
ATE234835T1 (de) 2003-04-15
JP3465820B2 (ja) 2003-11-10
EP1057828B1 (fr) 2003-03-19
DE60001687T2 (de) 2003-12-18
EP1057828A3 (fr) 2001-05-16
PT1057828E (pt) 2003-07-31
EP1057828A2 (fr) 2000-12-06
CA2311112A1 (fr) 2000-12-04
BR0002577A (pt) 2001-01-02
ES2194677T3 (es) 2003-12-01
JP2000344770A (ja) 2000-12-12
US6239141B1 (en) 2001-05-29

Similar Documents

Publication Publication Date Title
DK1057828T3 (da) Orale trovafloxacin-suspensioner
IL165715A0 (en) 2-ureido-6-heteroaryl-3h-benzoimidazole-4-carboxylic acid derivatives, pharmaceutical compositions containing the same and methods for the preparation thereof
EA199901014A1 (ru) C-4"-замещенные макролидные производные
CY1111693T1 (el) Αντιιικοι παραγοντες
WO2003064431A3 (fr) Composes aminopiperidine, leur procede de preparation et compositions pharmaceutiques les contenant
BG101118A (en) Therapeutical compounds
CA2292359A1 (fr) Nouveaux azalides et procede de fabrication
YU41500A (sh) Novi makrolidi
EA201000643A1 (ru) Замещенное производное этилендиамина для лечения микобактериальных заболеваний и фармацевтическая композиция на его основе
DK1200412T3 (da) Antiproliferative imidazolforbindelser
NO996108L (no) 9-oksinerytromycinderivater
AP9801378A0 (en) 9-amino-3- keto erythromycin derivatives.
TR200102128T2 (tr) Ketolid antibiyotikler
EE200200208A (et) Oligosahhariidid, nende valmistamismeetod ja kasutamine ning farmatseutilised kompositsioonid
GT199900208A (es) Antibiòticos cetòlidos carbamato y carbazato.
HUP0004282A2 (hu) 2-Halogén-6-0-szubsztituált ketolidszármazékok
DE69917717D1 (de) C11-Carbamate von antibakteriellen Makroliden
DE60208404D1 (de) Kreuzverquerte glycopeptid-cephalosporin-antibiotika
AP9801377A0 (en) Tricyclic erythromycin derivatives.
AP9801235A0 (en) Erythromycin derivatives.
DE60039122D1 (de) 6-o-alkyl-2-nor-2-substituierte ketolidderivate
ATE286728T1 (de) Verwendung von homocysteinderivaten zur behandlung von bakteriellen infektionen
BR9902049A (pt) Derivados 9a,11b-desidro de 9-oxima-3-ceto-6-o-metileritromicina.
GB9926301D0 (en) Novel compounds